Oramed Pharmaceuticals (FRA:OJU1) Other Long Term Assets : €1.38 Mil (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Oramed Pharmaceuticals Other Long Term Assets?

Oramed Pharmaceuticals's other long-term assets for the quarter that ended in Mar. 2024 was €1.38 Mil.

Oramed Pharmaceuticals's quarterly other long-term assets increased from Sep. 2023 (€0.03 Mil) to Dec. 2023 (€1.35 Mil) and increased from Dec. 2023 (€1.35 Mil) to Mar. 2024 (€1.38 Mil).

Oramed Pharmaceuticals's annual other long-term assets declined from Aug. 2021 (€21.28 Mil) to Dec. 2022 (€0.03 Mil) but then increased from Dec. 2022 (€0.03 Mil) to Dec. 2023 (€1.35 Mil).

Oramed Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Oramed Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oramed Pharmaceuticals Other Long Term Assets Chart

Oramed Pharmaceuticals Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

0.02

21.28

0.03

1.35

Oramed Pharmaceuticals Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															0.03	0.03	0.03	1.35	1.38

Oramed Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Oramed Pharmaceuticals (FRA:OJU1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oramed Pharmaceuticals Inc (FRA:OJU1) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ORMP:USA

Address

1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036

Website

https://www.oramed.com

Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.

Oramed Pharmaceuticals (FRA:OJU1) Headlines

No Headlines